Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.
- DOI
- 10.1007/s13555-026-01745-7
- Published
- 2026 Jun
- Container
- Dermatology and therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s13555-026-01745-7,
title = {Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.},
author = {Paller AS and Cork MJ and Hong HC and Soong W and Schneider SKR and Lo H and Vinther F and Thøgersen P and Wollenberg A},
year = {2026},
journal = {Dermatology and therapy},
doi = {10.1007/s13555-026-01745-7},
url = {https://doi.org/10.1007/s13555-026-01745-7}
}RIS
TY - JOUR TI - Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial. AU - Paller AS AU - Cork MJ AU - Hong HC AU - Soong W AU - Schneider SKR AU - Lo H AU - Vinther F AU - Thøgersen P AU - Wollenberg A PY - 2026 JO - Dermatology and therapy DO - 10.1007/s13555-026-01745-7 UR - https://doi.org/10.1007/s13555-026-01745-7 ER -
APA
AS, P., MJ, C., HC, H., W, S., SKR, S., H, L., F, V., P, T., & A, W. (2026). Clinical Laboratory Parameters in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52 in the Phase 3 ECZTRA 6 Trial.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01745-7
Source records
- pubmed · retrieved 2026-09-25T19:23:27.667Z